These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7982259)

  • 1. A cost-benefit analysis of four hormonal contraceptive methods.
    Ortmeier BG; Sauer KA; Langley PC; Bealmear BK
    Clin Ther; 1994; 16(4):707-13. PubMed ID: 7982259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative cost effectiveness of Depo-Provera, Implanon, and Mirena in reversible long-term hormonal contraception in the UK.
    Varney SJ; Guest JF
    Pharmacoeconomics; 2004; 22(17):1141-51. PubMed ID: 15612832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol.
    Reisman H; Martin D; Gast MJ
    Am J Obstet Gynecol; 1999 Nov; 181(5 Pt 2):45-52. PubMed ID: 10561675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Back up contraception].
    Dacheva T
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():28-31. PubMed ID: 19504704
    [No Abstract]   [Full Text] [Related]  

  • 5. [Escapelle - a method of choice for emergency contraception ].
    Tanchev L
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():24-7. PubMed ID: 19496450
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-acting steroids provide new options.
    Netw Res Triangle Park N C; 1988; 9(3):1-3, 7. PubMed ID: 12315656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
    Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
    Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injectable and implantable contraceptives.
    Cullins VE
    Curr Opin Obstet Gynecol; 1992 Aug; 4(4):536-43. PubMed ID: 1387011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA; Smith RD; Blair JM; Dwyer J; Brown RT
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuous Norethisterone Acetate versus Cyclical Drospirenone 3 mg/Ethinyl Estradiol 20 μg for the Management of Primary Dysmenorrhea in Young Adult Women.
    Al-Jefout M; Nawaiseh N
    J Pediatr Adolesc Gynecol; 2016 Apr; 29(2):143-7. PubMed ID: 26342733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
    American Health Consultants
    Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emergency contraception ].
    Amaliev G
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():19-24. PubMed ID: 19504703
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of levonorgestrel subdermal implants. Comparison with other contraceptive methods available in the United States.
    Ashraf T; Arnold SB; Maxfield M
    J Reprod Med; 1994 Oct; 39(10):791-8. PubMed ID: 7837126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraception, 1986. Currently available formulations.
    Hale R
    J Reprod Med; 1986 Jun; 31(6 Suppl):557-8. PubMed ID: 3088272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three triphasic oral contraceptives now available in U.S.
    Contracept Technol Update; 1985 Jan; 6(1):1-2, 4. PubMed ID: 12279912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant.
    Harel Z; Biro FM; Kollar LM; Rauh JL
    J Adolesc Health; 1996 Aug; 19(2):118-23. PubMed ID: 8863083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethinylestradiol + etonogestrel contraceptive vaginal ring: new drug. Possibly useful in some situations.
    Prescrire Int; 2006 Apr; 15(82):50-3. PubMed ID: 16604729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone.
    Hendrix CW; Jackson KA; Whitmore E; Guidos A; Kretzer R; Liss CM; Shah LP; Khoo KC; McLane J; Trapnell CB
    Clin Pharmacol Ther; 2004 May; 75(5):464-75. PubMed ID: 15116059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasomotor symptoms and estrogen-progestogen therapy.
    von Schoultz B
    Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of premature ovarian failure trial: description of an ongoing clinical trial.
    Cartwright B; Robinson J; Rymer J
    Menopause Int; 2010 Mar; 16(1):18-22. PubMed ID: 20424282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.